Table I.
miR-92b-3p expression | |||||
---|---|---|---|---|---|
Features | Category | Total patients | Low, n=50 | High, n=58 | P-value |
Age, years | 0.685 | ||||
<60 | 41 | 20 | 21 | ||
≥60 | 67 | 30 | 37 | ||
PSA, ng/ml | 0.009 | ||||
<10 | 34 | 22 | 12 | ||
≥10 | 74 | 28 | 46 | ||
Bone metastasis | 0.033 | ||||
Negative | 55 | 31 | 24 | ||
Positive | 53 | 19 | 34 | ||
Gleason score | 0.001 | ||||
≤7 | 59 | 36 | 23 | ||
>7 | 49 | 14 | 35 | ||
TNM stage | 0.015 | ||||
I–II | 47 | 28 | 19 | ||
III–IV | 61 | 22 | 39 |
PSA, prostate-specific antigen; TNM, tumor-node-metastasis; PCa, prostate cancer.